CAR T-cell Therapy can be a life-saving targeted treatment, but many people don't know they're eligible. Dr. Kent Holland helps us bust that myth.
This episode will focus on CAR T-cell Therapy.
Dr. H. Kent Holland, is board certified in the subspecialties of oncology and hematology. He is Medical Director of the Blood and Marrow Transplant Program at Northside Hospital and Co-Director of the Northside Hospital Stem Cell Processing Laboratory. Dr. Holland is also a Northside Hospital Leukemia Program physician. An expert on this topic, Dr. Holland will share how it works, who is eligible, and much more.
CAR T-cell Therapy is a game changer. Listen to learn more about this therapy and the many patients who will qualify. Many who may have very few options after relapsing from remission are learning that CAR T-cell Therapy is life-saving, targeted cellular therapy.
Get ready to be educated, inspired and much more as we bust this myth and many others throughout this series.
The information in this podcast should not be construed as medical advice. Please consult with your health care provider regarding your medical decisions and treatment. The listed resources are not intended to be endorsements.
For additional resources from the National Bone Marrow Transplant Link, visit us online at nbmtlink.org or call us at 800-546-5268.
This season of Marrow Masters is sponsored by the nbmtLINK, Seattle Genetics, and our esteemed link partners.